Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Cellebrite DI Ltd. (NASDAQ:CLBT) have been given an average recommendation of “Moderate Buy” by the five ratings firms that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $21.75.

A number of research firms recently weighed in on CLBT. Wall Street Zen raised shares of Cellebrite DI from a “hold” rating to a “buy” rating in a report on Friday, September 26th. Needham & Company LLC decreased their price target on shares of Cellebrite DI from $24.00 to $18.00 and set a “buy” rating on the stock in a report on Thursday, August 14th. JPMorgan Chase & Co. increased their price objective on Cellebrite DI from $20.00 to $23.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 24th. Lake Street Capital decreased their target price on Cellebrite DI from $24.00 to $22.00 and set a “buy” rating on the stock in a research note on Friday, August 15th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Cellebrite DI in a report on Wednesday, October 8th.

Hedge Funds Weigh In On Cellebrite DI

Institutional investors have recently made changes to their positions in the stock. Financial Management Professionals Inc. bought a new stake in shares of Cellebrite DI in the 3rd quarter valued at about $28,000. CWM LLC increased its stake in Cellebrite DI by 85.7% in the 3rd quarter. CWM LLC now owns 1,560 shares of the company’s stock worth $29,000 after purchasing an additional 720 shares during the period. Signaturefd LLC lifted its position in Cellebrite DI by 68.3% in the second quarter. Signaturefd LLC now owns 2,019 shares of the company’s stock valued at $32,000 after purchasing an additional 819 shares during the last quarter. Assetmark Inc. bought a new stake in Cellebrite DI in the first quarter valued at approximately $33,000. Finally, PNC Financial Services Group Inc. boosted its stake in shares of Cellebrite DI by 1,998.0% during the second quarter. PNC Financial Services Group Inc. now owns 2,098 shares of the company’s stock valued at $34,000 after purchasing an additional 1,998 shares during the period. Institutional investors own 45.88% of the company’s stock.

Cellebrite DI Stock Performance

Shares of NASDAQ CLBT opened at $17.06 on Monday. Cellebrite DI has a fifty-two week low of $13.10 and a fifty-two week high of $26.30. The stock has a market cap of $4.09 billion, a PE ratio of -22.45, a price-to-earnings-growth ratio of 3.16 and a beta of 1.29. The stock has a fifty day moving average of $17.80 and a 200-day moving average of $16.85.

Cellebrite DI (NASDAQ:CLBT) last issued its earnings results on Thursday, August 14th. The company reported $0.12 EPS for the quarter, topping the consensus estimate of $0.11 by $0.01. Cellebrite DI had a positive return on equity of 23.92% and a negative net margin of 34.56%.The business had revenue of $113.28 million during the quarter, compared to the consensus estimate of $112.33 million. During the same quarter last year, the company earned $0.10 EPS. The firm’s revenue was up 18.4% compared to the same quarter last year. Cellebrite DI has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, sell-side analysts predict that Cellebrite DI will post 0.3 EPS for the current year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.